Deroy & Devereaux Private Investment Counsel’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-4,170
Closed -$242K 167
2023
Q3
$242K Sell
4,170
-227,081
-98% -$13.9M 0.02% 163
2023
Q2
$14.8M Sell
231,251
-7,814
-3% -$524K 1.03% 52
2023
Q1
$16.6M Sell
239,065
-955
-0.4% -$67.4K 1.26% 37
2022
Q4
$17.3M Buy
240,020
+1,610
+0.7% +$121K 1.33% 34
2022
Q3
$16.9M Sell
238,410
-458
-0.2% -$33.2K 1.47% 30
2022
Q2
$18.4M Buy
238,868
+5,815
+2% +$443K 1.52% 31
2022
Q1
$17M Buy
233,053
+2,232
+1% +$150K 1.24% 44
2021
Q4
$14.4M Sell
230,821
-3,634
-2% -$213K 1.06% 55
2021
Q3
$13.9M Sell
234,455
-1,470
-0.6% -$96.8K 1.08% 53
2021
Q2
$15.8M Buy
235,925
+52
+0% +$3.39K 1.19% 50
2021
Q1
$14.9M Sell
235,873
-1,812
-0.8% -$113K 1.18% 49
2020
Q4
$14.7M Sell
237,685
-16,860
-7% -$1.04M 1.31% 42
2020
Q3
$15.3M Sell
254,545
-1,407
-0.5% -$84.7K 1.61% 29
2020
Q2
$15.1M Buy
255,952
+40,836
+19% +$2.44M 1.66% 28
2020
Q1
$12M Buy
+215,116
New +$13.1M 1.57% 32

Other funds holding BMY

Deroy & Devereaux Private Investment Counsel's BMY Position: Q4 2023 in Review

Deroy & Devereaux Private Investment Counsel sold out of Bristol-Myers Squibb (BMY) in Q4 2023, closing a stake of 4,170 shares — an estimated $242K sold.

Deroy & Devereaux Private Investment Counsel first reported a position in BMY in Q1 2020 and held it in 15 quarters. The position peaked at $18.4M in Q2 2022. 2,365 funds tracked by Wall St. Rank hold BMY as of Q4 2023.

  • Deroy & Devereaux Private Investment Counsel reported no remaining Bristol-Myers Squibb position as of Q4 2023 after selling out during the quarter.
  • Deroy & Devereaux Private Investment Counsel sold 4,170 Bristol-Myers Squibb shares in Q4 2023, an estimated $242K.
  • Deroy & Devereaux Private Investment Counsel first reported a position in Bristol-Myers Squibb in Q1 2020 and held it in 15 quarters.
  • Deroy & Devereaux Private Investment Counsel's Bristol-Myers Squibb position peaked at $18.4M in Q2 2022.
  • 2,365 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2023.

Based on Deroy & Devereaux Private Investment Counsel's 13F filing for Q4 2023, filed 29 Jan 2024.